Select a month January 2004 December 2003 November 2003" October 2003 September 2003 July 2003 June 2003 May 2003 April 2003 March 2003 February 2003 January 2003 December 2002 November 2002 October 2002 September 2002 August 2002 July 2002 June 2002 May 2002 April 2002 March 2002 February 2002 January 2002 December 2001 November 2001 October 2001

Studies in Humans: Studies of Ecstasy Users (Definition) Jump to: 2003: January  |  February  |  March  |  April  |   May  |   June  |   July  |   2002: January  |  February  |  March  |  April  |  May  |  June  |  July  |  August  |  September  |  October  |  November  |  December   2001: October  |  November  |  December July 2003 No updates available for July 2003 June 2003 Curran HV, Verheyden SL (2003) Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology 169: 91-103 Zhou JF, Zhou YH, Zhang L, Chen HH, Cai D (2003) 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage. Biomed Environ Sci 16: 53-61. May 2003 Daumann J, Fimm B, Willmes K, Thron A, Gouzoulis-Mayfrank E (2003) Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study. Cogn Brain Res 16: 479-87. Zhou JF , Chen P, Zhou YH, Zhang L, Chen HH (2003) 3,4-Methylenedioxymethamphetamine (MDMA) Abuse may Cause Oxidative Stress and Potential Free Radical Damage. Free Radical Research, 37 491-497 April 2003 Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167: 85-96. March 2003 Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M (2003) Long-term effects of "Ecstasy" use on serotonin transporters of the brain investigated by PET. J Nucl Med 44: 375-84. February 2003 No updates available for February 2003 January 2003 No updates available for January 2003 December 2002 Simon NG, Mattick RP (2002) The impact of regular ecstasy use on memory function. Addiction 97: 1523-1529. November 2002 Gijsman HJ, Van Gerven JM, Verkes RJ, Schoemaker RC, Pieters MS, Pennings EJ, Hessing TJ, Cohen AF (2002) Saccadic peak velocity and EEG as end-points for a serotonergic challenge test. Hum Psychopharmacology 17: 83-89. Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J (2002) Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacology 17: 309-312. October 2002 No updates available for October 2002 September 2002 Gerra G, Zaimovic A, Moi G, Giusti F, Gardini S, Delsignore R, Laviola G, Macchia T, Brambilla F (2002) Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans. Behav Brain Res 134: 403-410. Lieb R, Schuetz CG, Pfister H, von Sydow K, Wittchen H (2002). Mental disorders in ecstasy users: A prospective-longitudinal investigation. Drug Alcohol Depend 68: 195-207. Zakzanis KK, Young DA, Radkhoshnoud NF (2002) Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users. Appl Neuropsychol 9: 84-91. August 2002 Nixon PJ, Youngson CC, Beese A (2002) Tooth surface loss: does recreational drug use contribute? Clin Oral Investig 6: 128-30. July 2002 Stuerenburg HJ, Petersen K, Baumer T, Rosenkranz M, Buhmann C, Thomasius R (2002). Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users. Neuroendocrinol Lett 23: 259-61. June 2002 Fox, HC, McLean, A, Turner, JJD, Parrott, AC, Rogers R, Sahakian BJ (2002). Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users. Psychopharmacology (Berl)., 162: 203-214 Obrocki J, Schmoldt A, Buchert R, Andresen B, Petersen K, Thomasius R (2002). Specific neurotoxicity of chronic use of ecstasy. Toxicol Lett 127: 285-97 May 2002 Gouzoulis-Mayfrank E, Becker S, Pelz S, Tuchtenhagen F, Daumann J (2002). Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: Is it ecstasy or cannabis? Biological Psychiatry, 51, 766-769 Verheyden SL, Hadfield J, Calin T, Curran HV (2002). Sub-acute effects of MDMA (3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology (Berl), 161: 23-31 April 2002 No updates available for April 2002 March 2002 Reneman L, Majoie CB, Flick H, den Heeten GJ (2002). Reduced N-acetylaspartate levels in the frontal cortex of 3,4- methylenedioxymethamphetamine (Ecstasy) users: preliminary results. AJNR Am J Neuroradiol, 23: 231-237 Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff F, Booij J (2002). The acute and chronic effects of MDMA ("Ecstasy") on cortical 5HT2A receptors in rat and human brain. Neuropsychopharmacology, 26: 387-396 February 2002 Morgan, MJ, McFie, L, Fleetwood, LH and Robinson, JA (2002). Ecstasy (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology (Berl), 159: 294-303 Reneman L, Booij, J, Lavalaye, J, de Bruin, K, Reitsma, JB, Boudewijn Gunning, W., den Heeten, GJ, van den Brink, W (2002). Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: A [123I]-Beta-CIT SPECT study - preliminary report. Psychopharmacology (Berl). 159: 335-340. January 2002 Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E (2001). Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharmacol Clin Exp, 16:627-633 Dughiero G, Schifano F, Forza G (2001). Personality dimensions and psychopathological profiles of Ecstasy users. Hum Psychopharmacol Clin Exp, 16: 635-639 Fox HC, Toplis AS, Turner JJD, Parrott AC (2001). Auditory verbal learning in drug-free polydrug users. Human Psychopharmacol Clin Exp, 16: 613-618 Fox, HC, Parrott, AC and Turner, JJD (2001). Ecstasy use; Cognitive deficits related to dosage rather than to self-reported problematic use of the drug. J of Psychopharmacology, 15: 273-281 Gerra G, Zaimovic A, Ampollini R, Giusti F, Delsignore R, Raggi MA, Laviola G, Macchia T, Brambilla F (2001). Experimentally induced aggressive behavior in subjects with 3,4- methylenedioxy-methamphetamine ("Ecstasy") use history: psychobiological correlates. J Subst Abuse 13: 471-91 Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J (2001). Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy. Human Psychopharmacol, 16: 607-612 (Study 1) Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J (2001). Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy. Human Psychopharmacol, 16: 607-612 (Study 2) Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J (2001). Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy. Human Psychopharmacol, 16: 607-612 (Study 3) Parrott AC, Milani RM, Parmar R, Turner JD (2001). Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology (Berl) 159: 77-82. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott A (2001). Differential effects of ecstasy and cannabis on self-reports of memory ability; a web-based study. Hum Psychopharmacol Clin Exp, 16: 619-625 December 2001 Reneman, L, Booij, J, de Bruin, K, Reitsma, JB, de Wolfe, FA, Gunning, WB, den Heeten, GJ, van den Brink, W (2001). Effects of dose, sex and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet, 358: 1864-1869. November 2001 Obergriesser, T, Ende, G, Braus, DF and Henn, FA (2001). Hippocampal 1-HMRSI in ecstasy users. European Archives of Psychiatry and Clinical Neuroscience, 251: 114-116. Reneman, L, Lavalaye, J, Schmand, B, de Wolff, FA, van den Brink, W, den Heeten, GJ and Booij, J (2001). Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"): Preliminary findings. Archives of General Psychiatry, 58: 901-906. Reneman, L, Majoie, CBLM, Schmand, B, van den Brink, W and den Heeten, GJ (2001). Pre-frontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: Preliminary report. Biological Psychiatry, 50: 550-554. Zakzanis, KK and Young, DA (2001). Executive function in abstinent MDMA ("ecstasy") users. Medical Science Monitor, 7: 1292-1298. October 2001 Croft, RJ, Klugman, A, Baldeweg, T and Gruzelier, JH (2001). Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users. American Journal of Psychiatry, 158: 1687-1692